FT
Fortrea Holdings Inc. (FTRE)
NASDAQ·Healthcare·Biotechnology
$10.65
+0.47%
Mkt Cap $916.30M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $665.22M | $660.50M | -0.71% | $0.16 | $0.09 | -43.75% | — | — |
| Q4 2025 Nov 5, 2025 | $665.22M | $701.30M | +5.42% | $0.16 | $0.12 | -25.00% | — | — |
| Q3 2025 Aug 6, 2025 | $623.37M | $710.30M | +13.94% | $0.06 | $0.19 | +216.67% | — | — |
| Q2 2025 May 12, 2025 | $610.91M | $651.30M | +6.61% | -$0.07 | $0.02 | +128.57% | — | — |
| Q1 2025 Mar 3, 2025 | $660.98M | $697.00M | +5.45% | $0.36 | $0.18 | -50.00% | — | — |
| Q4 2024 Nov 8, 2024 | $703.90M | $674.90M | -4.12% | $0.27 | $0.23 | -14.81% | — | — |
| Q3 2024 Aug 12, 2024 | $689.08M | $662.40M | -3.87% | $0.07 | -$0.03 | -142.86% | — | — |
| Q2 2024 May 13, 2024 | $754.58M | $662.10M | -12.26% | -$0.01 | -$0.04 | -619.42% | — | — |
| Q1 2024 Mar 11, 2024 | $779.09M | $775.40M | -0.47% | $0.23 | $0.19 | -17.39% | — | — |
| Q4 2023 Nov 13, 2023 | $748.90M | $776.40M | +3.67% | $0.18 | $0.24 | +33.33% | — | — |
| Q3 2023 Aug 14, 2023 | $771.51M | $793.00M | +2.79% | $0.39 | $0.52 | +33.33% | — | — |
| Q1 2023 Mar 31, 2023 | — | $764.20M | — | — | -$0.13 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | $3.10B | — | — | $0.45 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | $762.30M | — | — | $0.69 | — | — | — |
| Q2 2022 Jun 29, 2022 | — | $793.10M | — | — | $0.75 | — | — | — |
| Q1 2022 Mar 30, 2022 | — | $779.00M | — | — | $0.37 | — | — | — |